Transform raw SEC Edgar data into actionable insights. See what company insiders are really doing, before the market catches on.
Start by searching a company name or ticker symbol above to unlock detailed visualizations.
Our interactive stock charts map out price history alongside every buy and sell transaction by company insiders, complete with volume data. Instantly spot trends and significant activities sourced directly from SEC filings.
Go beyond simple trades. Our transaction volume bar charts clearly identify the largest buyers and sellers within a company, revealing who holds the most conviction and potential influence derived from SEC data.
Track the largest shareholders and monitor how their positions evolve over your chosen timeframe. Understand ownership concentration and significant changes in holdings with our detailed breakdown, all from SEC filings.
Navigate the sea of insider trading data with ease. Our powerful and intuitive filters let you zero in on specific transaction types, insiders, date ranges, dollar amounts, and more, giving you exactly the information you need from SEC reports.
At Penguin Stock, we're committed to providing the most accurate and timely insider trading information, sourced directly from official SEC Edgar filings. Our platform is designed for an unparalleled user experience, empowering you to make informed decisions. Discover the transparency and power of raw financial data, beautifully visualized to give you an edge in analyzing stock trends and shareholder activity.
| Name | Last Transaction | Δ Change | Shares Owned | Value Owned | % of Company Owned |
|---|---|---|---|---|---|
|
Joaquin Duato
CEO and Chairman of the Board
|
--
--
|
11.98%
|
--
|
0.02%
|
|
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
--
--
|
14.96%
|
--
|
0.01%
|
|
|
Peter Fasolo
Exec VP, Chief HR Officer
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
--
--
|
14.61%
|
--
|
0.00%
|
|
|
Joseph J Wolk
Exec VP, CFO
|
--
--
|
20.24%
|
--
|
0.00%
|
|
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
William Hait
EVP, Chief EI and Med Officer
|
--
--
|
0.00%
|
--
|
0.00%
|
|
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
--
--
|
18.96%
|
--
|
0.00%
|
|
|
Robert J Decker
VP Corporate Controller
|
--
--
|
10.69%
|
--
|
0.00%
|
|
|
James D. Swanson
EVP, CIO
|
--
--
|
29.37%
|
--
|
0.00%
|
|
|
Timothy Schmid
EVP, WW Chair, MedTech
|
--
--
|
29.52%
|
--
|
0.00%
|
|
|
Kristen Mulholland
EVP, Chief HR Officer
|
--
--
|
--
|
--
|
0.00%
|
|
|
Elizabeth Forminard
Executive VP, General Counsel
|
--
--
|
54.11%
|
--
|
0.00%
|
|
|
John C Reed
EVP, Innovative Medicine, R&D
|
--
--
|
-26.88%
|
--
|
0.00%
|
|
|
Mark A Weinberger
|
--
--
|
--
|
--
|
0.00%
|
|
|
Eugene A. Woods
|
--
--
|
--
|
--
|
0.00%
|
|
|
Total
|
1,083,920 | -- |
0.05%
|
| DATE | INSIDER & POSITION | TRANSACTION | % CHANGE | SHARES | PRICE | AMOUNT | NOTES |
|---|---|---|---|---|---|---|---|
|
09/04/25
Filed: *09/05/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+24.08% | 56,471 | $101.87 | $5,752,701 | |
|
09/04/25
Filed: *09/05/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
Open Market Sell
|
-31.72% | 56,471 | $177.81 | $10,040,883 | |
|
08/29/25
Filed: *09/03/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+51.38% | 11,521 | $115.67 | $1,332,634 | |
|
08/29/25
Filed: *09/03/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-74.46% | 9,570 | $177.20 | $1,695,804 | |
|
08/22/25
Filed: *08/25/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+31.32% | 125,824 | $101.87 | $12,817,691 | |
|
08/22/25
Filed: *08/25/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Open Market Sell
|
-45.59% | 125,824 | $179.21 | $22,548,655 | |
|
08/15/25
Filed: *08/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+54.57% | 16,820 | $101.87 | $1,713,453 | |
|
08/15/25
Filed: *08/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-120.14% | 16,820 | $176.91 | $2,975,571 | |
|
07/17/25
Filed: 07/18/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
Open Market Sell
|
-179.56% | 19,137 | $163.55 | $3,129,830 | |
|
05/01/25
Filed: *05/05/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+61.90% | 25,255 | N/A | $0 | |
|
05/01/25
Filed: *05/05/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-36.93% | 11,002 | $156.31 | $1,719,723 | |
|
03/18/25
Filed: *03/19/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Bona Fide Gift
|
-47.42% | 130,852 | N/A | $0 | |
|
03/18/25
Filed: *03/19/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Bona Fide Gift
|
+100.00% | 130,852 | N/A | $0 | |
|
12/31/24
Filed: 02/28/25
|
Eugene A. Woods
|
Buy
Open Market Buy
|
+40.00% | 100 | $145.53 | $14,553 | |
|
02/25/25
Filed: *02/26/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+25.00% | 6,999 | $101.87 | $712,988 | |
|
02/25/25
Filed: *02/26/25
|
Robert J Decker
VP Corporate Controller
|
Sell
Open Market Sell
|
-33.33% | 6,999 | $165.88 | $1,160,994 | |
|
02/14/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+15.67% | 2,806 | N/A | $0 | |
|
02/14/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-6.01% | 1,015 | $156.71 | $159,061 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+3.69% | 499 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-1.45% | 193 | $155.26 | $29,965 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+11.68% | 1,765 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-4.42% | 639 | $156.71 | $100,138 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+6.64% | 1,029 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
Open Market Sell
|
-2.67% | 403 | $156.15 | $62,928 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.73% | 651 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.25% | 223 | $155.26 | $34,623 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+1.68% | 1,530 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.53% | 480 | $156.71 | $75,221 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.67% | 607 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.22% | 200 | $156.15 | $31,230 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+6.04% | 5,837 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-2.54% | 2,393 | $156.71 | $375,007 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+100.00% | 1,779 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-39.86% | 507 | $155.26 | $78,717 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+75.94% | 4,014 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-27.62% | 1,144 | $156.71 | $179,276 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+32.24% | 1,971 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-14.37% | 768 | $156.15 | $119,923 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+74.13% | 15,316 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-47.58% | 6,661 | $156.71 | $1,043,845 | |
|
02/15/25
Filed: *02/18/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+8.48% | 1,350 | N/A | $0 | |
|
02/15/25
Filed: *02/18/25
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-2.48% | 385 | $156.15 | $60,118 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.78% | 1,302 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.25% | 410 | $155.26 | $63,657 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+2.37% | 4,053 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.80% | 1,348 | $156.71 | $211,245 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.93% | 1,594 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.38% | 651 | $156.15 | $101,654 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+8.32% | 15,465 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-4.44% | 7,911 | $156.71 | $1,239,733 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+2.98% | 447 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-1.02% | 152 | $155.26 | $23,600 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+11.65% | 1,961 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-3.43% | 558 | $156.71 | $87,444 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+2.94% | 492 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-0.85% | 141 | $156.15 | $22,017 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+15.80% | 3,118 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-4.72% | 889 | $156.71 | $139,315 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+3.40% | 411 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-1.18% | 141 | $155.26 | $21,892 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+7.77% | 1,007 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-2.29% | 290 | $156.71 | $45,446 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+3.20% | 419 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.92% | 120 | $156.15 | $18,738 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Buy
Option Exercised
|
+10.98% | 1,601 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Kristen Mulholland
EVP, Chief HR Officer
|
Sell
For Tax Liability
|
-3.24% | 457 | $156.71 | $71,616 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+7.24% | 651 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-2.45% | 215 | $155.26 | $33,381 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+8.84% | 851 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-2.85% | 267 | $156.71 | $41,842 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+9.31% | 961 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-3.07% | 307 | $156.15 | $47,938 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+11.90% | 1,352 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-4.26% | 464 | $156.71 | $72,713 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+0.88% | 3,470 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.39% | 1,510 | $155.26 | $234,443 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.28% | 5,053 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.56% | 2,198 | $156.71 | $344,449 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+0.93% | 3,682 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.40% | 1,602 | $156.15 | $250,152 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+4.64% | 19,282 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-2.06% | 8,386 | $156.71 | $1,314,170 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.62% | 312 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.54% | 104 | $155.26 | $16,147 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+4.24% | 850 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-1.28% | 254 | $156.71 | $39,804 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.69% | 339 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.47% | 94 | $156.15 | $14,678 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+6.32% | 1,351 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-1.77% | 372 | $156.71 | $58,296 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+2.02% | 408 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.75% | 151 | $155.26 | $23,444 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+8.35% | 1,830 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-2.69% | 574 | $156.71 | $89,952 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+2.25% | 492 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.73% | 158 | $156.15 | $24,672 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+11.83% | 2,910 | N/A | $0 | |
|
02/13/25
Filed: *02/18/25
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-4.23% | 997 | $156.71 | $156,240 | |
|
02/07/25
Filed: *02/11/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+25.81% | 126,369 | $100.06 | $12,644,482 | |
|
02/07/25
Filed: *02/11/25
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-25.87% | 100,643 | $153.12 | $15,410,456 | |
|
02/07/25
Filed: *02/11/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+28.48% | 32,762 | $100.06 | $3,278,166 | |
|
02/07/25
Filed: *02/11/25
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-29.31% | 26,076 | $153.12 | $3,992,757 | |
|
02/07/25
Filed: *02/11/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+27.42% | 58,504 | $100.06 | $5,853,910 | |
|
02/07/25
Filed: *02/11/25
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-28.59% | 47,436 | $153.12 | $7,263,400 | |
|
02/07/25
Filed: *02/11/25
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+100.00% | 13,015 | $100.06 | $1,302,281 | |
|
02/07/25
Filed: *02/11/25
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Open Market Sell
|
-N/A | 13,015 | $153.89 | $2,002,878 | |
|
12/12/24
Filed: 12/12/24
|
Mark A Weinberger
|
Buy
Open Market Buy
|
+100.00% | 1,000 | $147.22 | $147,220 | - |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+98.80% | 25,255 | N/A | $0 | |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-75.35% | 10,984 | $144.59 | $1,588,177 | |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Buy
Option Exercised
|
+98.80% | 25,255 | N/A | $0 | |
|
05/01/24
Filed: *10/31/24
|
John C Reed
EVP, Innovative Medicine, R&D
|
Sell
For Tax Liability
|
-75.35% | 10,984 | $144.59 | $1,588,177 | |
|
05/22/24
Filed: *10/21/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Bona Fide Gift
|
-0.08% | 55 | N/A | $0 | |
|
05/22/24
Filed: *10/21/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Bona Fide Gift
|
-N/A | 68,835 | N/A | $0 | |
|
05/22/24
Filed: *10/21/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Bona Fide Gift
|
+100.00% | 68,835 | N/A | $0 | |
|
08/30/24
Filed: *09/03/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+22.90% | 5,635 | $100.06 | $563,838 | |
|
08/30/24
Filed: *09/03/24
|
Robert J Decker
VP Corporate Controller
|
Sell
Open Market Sell
|
-29.70% | 5,635 | $165.06 | $930,113 | |
|
07/08/24
Filed: *07/09/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+39.47% | 9,809 | N/A | $0 | |
|
07/08/24
Filed: *07/09/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-25.30% | 5,018 | $147.16 | $738,449 | |
|
03/13/24
Filed: 03/13/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
Open Market Sell
|
-59.10% | 8,891 | $162.16 | $1,441,765 | |
|
02/13/24
Filed: *02/15/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+0.79% | 651 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-0.40% | 333 | $157.85 | $52,564 | |
|
02/13/24
Filed: *02/15/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+2.56% | 1,780 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-1.12% | 773 | $157.85 | $122,018 | |
|
02/13/24
Filed: *02/15/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+0.84% | 1,302 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-0.43% | 666 | $157.85 | $105,128 | |
|
02/13/24
Filed: *02/15/24
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+3.03% | 447 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-1.34% | 195 | $157.85 | $30,781 | |
|
02/13/24
Filed: *02/15/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+3.75% | 499 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-1.92% | 250 | $157.85 | $39,462 | |
|
02/13/24
Filed: *02/15/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+0.82% | 925 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.42% | 474 | $157.85 | $74,821 | |
|
02/13/24
Filed: *02/15/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+2.13% | 834 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-1.10% | 427 | $157.85 | $67,402 | |
|
02/13/24
Filed: *02/15/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+0.95% | 3,470 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.41% | 1,507 | $157.85 | $237,880 | |
|
02/13/24
Filed: *02/15/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+1.69% | 408 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-0.87% | 209 | $157.85 | $32,991 | |
|
02/13/24
Filed: *02/15/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+7.59% | 651 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-2.83% | 236 | $157.85 | $37,253 | |
|
02/13/24
Filed: *02/15/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.64% | 313 | N/A | $0 | |
|
02/13/24
Filed: *02/15/24
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-0.45% | 86 | $157.85 | $13,575 | |
|
02/12/24
Filed: *02/14/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+18.74% | 4,701 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Grant, Award
|
+3.05% | 790 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-9.00% | 2,136 | $157.40 | $336,206 | |
|
02/12/24
Filed: *02/14/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+18.64% | 7,647 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+3.04% | 1,285 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-10.66% | 4,076 | $157.40 | $641,562 | |
|
02/12/24
Filed: *02/14/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+29.50% | 22,119 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+4.72% | 3,716 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-15.93% | 10,816 | $157.40 | $1,702,438 | |
|
02/12/24
Filed: *02/14/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+28.64% | 2,448 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+4.59% | 411 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-13.05% | 1,034 | $157.40 | $162,752 | |
|
02/12/24
Filed: *02/14/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+13.69% | 22,433 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Buy
Option Exercised
|
+2.25% | 3,769 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine
|
Sell
For Tax Liability
|
-8.69% | 13,403 | $157.40 | $2,109,632 | |
|
02/12/24
Filed: *02/14/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+10.99% | 12,808 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+1.81% | 2,152 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-6.29% | 7,019 | $157.40 | $1,104,791 | |
|
02/12/24
Filed: *02/14/24
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+30.67% | 4,671 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
James D. Swanson
EVP, CIO
|
Buy
Option Exercised
|
+4.90% | 785 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
James D. Swanson
EVP, CIO
|
Sell
For Tax Liability
|
-11.84% | 1,695 | $157.40 | $266,793 | |
|
02/12/24
Filed: *02/14/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+8.43% | 31,351 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.40% | 5,267 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-4.40% | 15,900 | $157.40 | $2,502,660 | |
|
02/12/24
Filed: *02/14/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+33.06% | 4,911 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+5.26% | 825 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-22.57% | 2,887 | $157.40 | $454,414 | |
|
02/12/24
Filed: *02/14/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+8.62% | 1,637 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+1.43% | 275 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-2.79% | 523 | $157.40 | $82,320 | |
|
02/12/24
Filed: *02/14/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+13.59% | 11,826 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+2.23% | 1,987 | N/A | $0 | |
|
02/12/24
Filed: *02/14/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-8.62% | 7,066 | $157.40 | $1,112,188 | |
|
02/09/24
Filed: *02/13/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+34.76% | 35,638 | $90.44 | $3,223,101 | |
|
02/09/24
Filed: *02/13/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-36.35% | 27,333 | $156.76 | $4,284,721 | |
|
02/09/24
Filed: *02/13/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+29.81% | 130,969 | $90.44 | $11,844,836 | |
|
02/09/24
Filed: *02/13/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-28.97% | 98,662 | $156.76 | $15,466,255 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+2.61% | 3,739 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
For Tax Liability
|
-1.35% | 1,913 | $156.33 | $299,059 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Buy
Option Exercised
|
+29.58% | 59,397 | $90.44 | $5,371,865 | |
|
02/08/24
Filed: *02/12/24
|
Jennifer L Taubert
EVP, WW Chair, Pharmaceuticals
|
Sell
Open Market Sell
|
-42.00% | 59,397 | $156.27 | $9,281,969 | |
|
02/08/24
Filed: *02/12/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Buy
Option Exercised
|
+1.68% | 5,225 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
For Tax Liability
|
-0.74% | 2,269 | $156.33 | $354,713 | |
|
02/08/24
Filed: *02/12/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Buy
Option Exercised
|
+2.90% | 1,971 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer
|
Sell
For Tax Liability
|
-1.51% | 1,009 | $156.33 | $157,737 | |
|
02/08/24
Filed: *02/12/24
|
Joseph J Wolk
Exec VP, CFO
|
Buy
Option Exercised
|
+6.84% | 3,686 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Joseph J Wolk
Exec VP, CFO
|
Sell
For Tax Liability
|
-1.98% | 1,047 | $156.33 | $163,678 | |
|
02/08/24
Filed: *02/12/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Buy
Option Exercised
|
+15.15% | 979 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Elizabeth Forminard
Executive VP, General Counsel
|
Sell
For Tax Liability
|
-5.95% | 363 | $156.33 | $56,748 | |
|
02/08/24
Filed: *02/12/24
|
James D. Swanson
See Remarks
|
Buy
Option Exercised
|
+16.81% | 1,868 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
James D. Swanson
See Remarks
|
Sell
For Tax Liability
|
-5.25% | 554 | $156.33 | $86,607 | |
|
02/08/24
Filed: *02/12/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Buy
Option Exercised
|
+17.95% | 1,964 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Timothy Schmid
EVP, WW Chair, MedTech
|
Sell
For Tax Liability
|
-10.07% | 1,001 | $156.33 | $156,486 | |
|
02/08/24
Filed: *02/12/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Buy
Option Exercised
|
+2.04% | 2,135 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
For Tax Liability
|
-0.75% | 781 | $156.33 | $122,094 | |
|
02/08/24
Filed: *02/12/24
|
William Hait
See Remarks
|
Buy
Option Exercised
|
+8.87% | 3,059 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
William Hait
See Remarks
|
Sell
For Tax Liability
|
-3.33% | 1,113 | $156.33 | $173,995 | |
|
02/08/24
Filed: *02/12/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Buy
Option Exercised
|
+8.92% | 1,880 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Vanessa Broadhurst
EVP, Global Corp Affairs
|
Sell
For Tax Liability
|
-3.45% | 703 | $156.33 | $109,900 | |
|
02/08/24
Filed: *02/12/24
|
Robert J Decker
VP Corporate Controller
|
Buy
Option Exercised
|
+3.73% | 655 | N/A | $0 | |
|
02/08/24
Filed: *02/12/24
|
Robert J Decker
VP Corporate Controller
|
Sell
For Tax Liability
|
-1.24% | 215 | $156.33 | $33,611 | |
|
08/23/23
Filed: 08/25/23
|
William Hait
See Remarks
|
Sell
Disposition to the issuer
|
-0.80% | 696 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Ashley Mcevoy
EVP, WW Chair, MedTech
|
Sell
Disposition to the issuer
|
-5.36% | 2,787 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Disposition to the issuer
|
-0.23% | 232 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Joaquin Duato
CEO and Chairman of the Board
|
Sell
Disposition to the issuer
|
-3.61% | 11,035 | N/A | $0 | |
|
08/23/23
Filed: 08/25/23
|
Joseph J Wolk
Exec VP, CFO
|
Sell
Disposition to the issuer
|
-0.13% | 67 | N/A | $0 | |
|
07/25/23
Filed: 07/27/23
|
Peter Fasolo
Exec VP, Chief HR Officer
|
Sell
Open Market Sell
|
-19.47% | 20,000 | $170.32 | $3,406,498 |
* Dates marked with an asterisk indicate one of multiple transactions reported in the same filing.